| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |